s.cardoso
TL2 · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 13 March 2025 · last posted 7d · groups: regional-na
84 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #100 · Sourcing › Independent verification · 21 Jul 2026 · 12 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. I would treat that as a working…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #20 · Clinical › Prescriber conversations · 20 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #44 · Documentation › Doc review · 17 Jul 2026 · 10 likes I read the earlier replies on draft on reconstitution arithmetic twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #40 · Clinical › Prescriber conversations · 15 Jul 2026 · 9 likes I had written a reply contradicting post #38 and deleted it. Here is what survived. Prescription logistics: confirm whether it will be filled locally, requires mail…
-
Joined after a search result and stayed Replied, post #9 · Lounge › Introductions · 15 Jul 2026 · 0 likes Good to have another set of eyes on the wiki posts. Community wiki editing is open at trust level three and the queue of small corrections is permanently longer than…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #75 · Access › Insurance & coverage · 15 Jul 2026 · 10 likes Agreed on all of that, and I have nothing to add to it.
-
Fasting versus non-fasting and which tests care Replied, post #65 · Clinical › Bloodwork · 8 Jul 2026 · 6 likes Post #61 put the caveat in the right place and I want to underline it. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ…
-
Prescription portability between countries Replied, post #91 · Access › International · 8 Jul 2026 · 25 likes Adding the measurement that post #88 says would settle it. Where a compound is approved under a different trade name in another market, searching the local name finds…
-
How much context is too much context in a first post? Replied, post #26 · Start Here › How to Ask · 6 Jul 2026 · 26 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
CJC-1295 with and without DAC: what the modification does Replied, post #98 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 10 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #33 · Compounds › Repair & healing peptides · 22 Jun 2026 · 7 likes Post #31 and I disagree about the size of the effect, not about the direction. On identity: a short sequence gives a distinctive mass and a distinctive fragmentation…
-
A pooled estimate that changed when one trial was added Replied, post #10 · Evidence › Meta-analyses · 15 Jun 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #120 · Practice › Interactions · 6 Jun 2026 · 0 likes Trying to state the Metformin co-administration position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
Primary endpoint hierarchies and why order matters — one year on Started this topic · Evidence › Trials · 25 May 2026 · 33 likes On the subject in the title: Primary endpoint hierarchies and why order matters — one year on Working notes rather than a conclusion. A follow-up question about Primary…
-
Reading a home test result without over-claiming Replied, post #53 · Analytics › Home & field testing · 24 May 2026 · 1 like The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on arrival. It costs nothing and it is the evidence you…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #62 · Practice › Storage & stability · 20 May 2026 · 11 likes I read post #60 twice before replying, because I had assumed the opposite. Peptide is a question about a distribution, not about a value, and treating it as a value is…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #14 · Compounds › Retatrutide · 19 May 2026 · 19 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Official shortage notices and what they authorise Replied, post #21 · Access › Shortages · 26 Apr 2026 · 0 likes Two claims get bundled together under official shortage notices and they need separating. The descriptive one — this is what was observed — is usually well supported.…
-
Designing a personal experiment that could change your mind — one year on Replied, post #36 · Research Methods › N-of-1 designs · 21 Apr 2026 · 10 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. Not the answer, but…
-
Travelling with an injectable: documentation and practicalities Replied, post #22 · Access › International · 19 Apr 2026 · 10 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. I would put a…
-
Managing an unplanned gap in supply Replied, post #98 · Access › Shortages · 15 Apr 2026 · 1 like Post #94 describes the usual case. This is about the unusual one. Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to…
-
A calculator that gives a right answer to the wrong question Replied, post #14 · Data & Tools › Calculators · 8 Apr 2026 · 7 likes This follows post #13 rather than contradicting it. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #25 · Meta › Announcements · 3 Apr 2026 · 0 likes Post #24 is the version of this I will quote in future. One addition. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the…
-
Deletion sequences: expected mass shifts by residue Started this topic · Analytics › Impurities & related substances · 29 Mar 2026 · 39 likes Deletion sequences: expected mass shifts by residue — setting out what I have, and where I think it stops being reliable. Deletion sequences keeps being re-asked here…
-
Request: export my own posts — one year on Replied, post #62 · Meta › Feature requests · 21 Mar 2026 · 0 likes Post #59 is the version of this I will quote in future. One addition. Community support: if other people support your request, they can reply with "+1" or "I would use…
-
Liver enzymes drifting down and what that usually means Replied, post #68 · Clinical › Bloodwork · 19 Mar 2026 · 2 likes Post #67 is the version of this I will quote in future. One addition. A trend needs at least three points to be a trend. Two points are a line and a line through noise…
-
A parcel stationary at a customs facility for nine days Replied, post #39 · Sourcing › Logistics · 17 Mar 2026 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Second pass at: Sleep apnoea improving and the equipment implications Started this topic · Wellbeing › Sleep · 17 Mar 2026 · 2 likes On the subject in the title: Second pass at: Sleep apnoea improving and the equipment implications Working notes rather than a conclusion. Asking about sleep…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #117 · Documentation › Wiki requests · 2 Mar 2026 · 0 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. I looked this up rather than…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #49 · Practice › Reconstitution · 1 Mar 2026 · 6 likes Worth separating two things that post #45 runs together. The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume,…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #88 · Clinical › Bloodwork · 28 Feb 2026 · 27 likes My position on panel is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #28 · Analytics › Mass spectrometry · 12 Feb 2026 · 4 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Aggregates and why a purity assay may miss them entirely Replied, post #70 · Analytics › Impurities & related substances · 13 Jan 2026 · 1 like Adding thanks rather than a view. I do not have a view worth the space.
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #9 · Evidence › Trials · 12 Jan 2026 · 3 likes I would call the community position on Reading a supplementary appendix likely rather than established, and I would be comfortable defending that hedge.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #54 · Practice › Side effects · 8 Jan 2026 · 11 likes Injection-site reactions are usually local, brief and unremarkable. A reaction spreading over a day, or accompanied by systemic symptoms, is a different thing and needs…
-
Personal import allowances, compared — a second dataset Replied, post #39 · Access › International · 21 Dec 2025 · 0 likes Trying to state the Personal import allowances position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
The decimal-point error, and the habit that catches it Replied, post #76 · Practice › Reconstitution · 17 Dec 2025 · 2 likes Everything in post #75 holds. The case it does not cover is the one I have. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #27 · Practice › Dosing & titration · 13 Dec 2025 · 0 likes Where I part company with post #23, and it is a narrow parting. A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An…
-
Realistic expectations for strength while losing weight quickly Replied, post #44 · Nutrition & Training › Resistance training · 13 Dec 2025 · 1 like Everything in post #42 holds. The case it does not cover is the one I have. Counterpoint on realistic expectations for strength, offered without confidence: the same…
-
Micro-titration: a disputed topic, argued properly Replied, post #11 · Practice › Dosing & titration · 12 Dec 2025 · 12 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
DXA precision and the least significant change for lean mass Replied, post #23 · Outcomes › Body composition · 26 Nov 2025 · 6 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology. That is the…
-
Biological variation versus analytical imprecision — does this still hold? Replied, post #3 · Clinical › Bloodwork · 25 Nov 2025 · 6 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Coming back to: What the published dose-response for semaglutide actually looks like… Started this topic · Compounds › Semaglutide · 17 Nov 2025 · 59 likes The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody…
-
[2026 update] What steady state means for the decision to escalate Replied, post #9 · Practice › Dosing & titration · 4 Nov 2025 · 33 likes Second this, and I would have said it less carefully.
-
EMA product information as a primary source Replied, post #23 · Regional › European Union · 2 Nov 2025 · 30 likes EMA is the regulator with national implementation. Licensed incretin analogues are prescription-only across the EU, with some variation in specific approvals by member…
-
The most useful thing you learned here that was not the answer you came for Started this topic · Lounge › Off topic · 24 Oct 2025 · 1 like The most useful thing you learned here that was not the answer you came for Writing it up because I had to work it out twice and would rather nobody else did. A…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #93 · Compounds › Tirzepatide · 23 Oct 2025 · 0 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory. Two…
-
MHRA statements, read directly Replied, post #19 · Regional › UK & Ireland · 21 Oct 2025 · 28 likes Adding a data point of agreement rather than a data point.
-
Angle of injection and whether 90 degrees is always right Replied, post #38 · Practice › Administration · 20 Oct 2025 · 23 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #54 · Documentation › Doc review · 8 Sep 2025 · 0 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Reviewing your own nomination is fine and is not sufficient. Somebody else has to…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #6 · Evidence › Journal club · 1 Sep 2025 · 17 likes This follows post #3 rather than contradicting it. On step-hfpef and symptom endpoints the community has more anecdote than the confidence in this thread implies, and I…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #51 · Devices › Syringes & needles · 1 Sep 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Coming back to: Official shortage notices and what they authorise Replied, post #88 · Access › Shortages · 13 Aug 2025 · 30 likes Building on post #87 rather than restating it. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is…
-
Checking someone else's arithmetic: a worked example thread Replied, post #74 · Practice › Reconstitution · 4 Aug 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
A ten-fold dose error caught before injection — one year on Replied, post #99 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful.
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #17 · Practice › Dosing & titration · 27 Jul 2025 · 0 likes Worth separating two things that post #15 runs together. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point…
-
What a documentation review can and cannot tell you Replied, post #38 · Sourcing › Independent verification · 17 Jul 2025 · 15 likes This follows post #35 rather than contradicting it. What a supplier does when asked is itself information, and it is information that a chromatogram cannot provide.…
-
Coming back to: When "no data" is the complete and final answer Replied, post #33 · Compounds › Other compounds · 4 Jul 2025 · 31 likes The arithmetic in post #32 is right; the assumption feeding it is the part to check. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #10 · Analytics › HPLC & UHPLC · 28 Jun 2025 · 23 likes Everything in post #6 holds. The case it does not cover is the one I have. Change the wavelength and the proportions change even though the sample has not. That is the…
-
How to read a forest plot, properly, from scratch Started this topic · Evidence › Trials · 24 Jun 2025 · 0 likes The question in the title: How to read a forest plot, properly, from scratch I will give what I have already checked below so nobody repeats it. Reading STEP 4 ( JAMA ,…
-
Which panel is worth repeating and which is worth ignoring Replied, post #44 · Clinical › Bloodwork · 22 Jun 2025 · 0 likes Counterpoint on panel, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #126 · Devices › Cold chain · 19 Jun 2025 · 6 likes The interaction between cold chain and the storage question is that a warm transit spends part of the material's stability budget before it reaches you, and the budget…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #6 · Compounds › Tirzepatide · 18 Jun 2025 · 13 likes Where I part company with post #4, and it is a narrow parting. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #14 · Analytics › Method validation · 12 Jun 2025 · 27 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
High-resolution MS on aggregates and what it can see Replied, post #3 · Analytics › Mass spectrometry · 7 Jun 2025 · 18 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Resolution: "high resolution" commonly means
-
Criticising the method without criticising the authors — one year on Replied, post #5 · Evidence › Study critique · 5 Jun 2025 · 31 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. If that is already documented somewhere, ignore me and…
-
Pre-registering a personal experiment, seriously Replied, post #17 · Research Methods › N-of-1 designs · 26 May 2025 · 0 likes My position on pre-registering a personal experiment is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
A claim built entirely on a subgroup analysis Replied, post #16 · Evidence › Study critique · 3 May 2025 · 18 likes Where a critique rests on a subgroup, check whether the interaction was tested. A difference between subgroups that is not statistically supported is not a difference.…
-
Sequence verification for an obscure compound: how it is done Replied, post #21 · Compounds › Other compounds · 27 Apr 2025 · 25 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Reading an MS report that only gives you a single number Replied, post #63 · Analytics › Mass spectrometry · 26 Apr 2025 · 0 likes Picking up post #60: that is the part I would want checked first. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #26 · Devices › Pens & autoinjectors · 26 Apr 2025 · 8 likes Reading the dose window rather than the dial position is worth the habit. On several devices the two do not correspond in the way you would guess. Where I would look…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #73 · Access › International · 2 Mar 2025 · 0 likes Cross-border purchase within is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Validating a method you did not develop — does this still hold? Replied, post #13 · Analytics › Method validation · 15 Feb 2025 · 2 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Distinguishing a deletion sequence by mass alone Replied, post #73 · Analytics › Mass spectrometry · 11 Feb 2025 · 24 likes An honest declaration on distinguishing a deletion sequence: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #77 · Sourcing › Regulatory · 3 Feb 2025 · 12 likes I have been on both sides of the Research-use-only labelling argument in this category within eighteen months, which should tell you how strong the evidence for either…
-
Individual participant data versus aggregate data Replied, post #17 · Evidence › Meta-analyses · 2 Feb 2025 · 6 likes Post #13 and I disagree about the size of the effect, not about the direction. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #2 · marked as the solution · Compounds › Tirzepatide · 6 Jan 2025 · 16 likes Taking the opening post at face value and following it one step further. Tirzepatide's half-life of roughly five days means steady state is approached in about three…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #115 · Compounds › Tirzepatide · 28 Dec 2024 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #47 · Compounds › Semaglutide · 21 Dec 2024 · 0 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #20 · Compounds › Repair & healing peptides · 18 Dec 2024 · 19 likes Building on post #17 rather than restating it. Where I have landed on TB-500 and thymosin beta-4, having got it wrong once in public: the direction is clear, the…
-
Washout with a one-week half-life: the arithmetic Replied, post #80 · Research Methods › N-of-1 designs · 7 Dec 2024 · 2 likes I read post #77 twice before replying, because I had assumed the opposite. Where I have landed on washout, having got it wrong once in public: the direction is clear,…
-
What we do not know about retatrutide, listed explicitly Replied, post #10 · Compounds › Retatrutide · 2 Dec 2024 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #17 · Clinical › Special populations · 14 Nov 2024 · 30 likes I read post #15 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #21 · Compounds › Repair & healing peptides · 9 Nov 2024 · 9 likes Adding the measurement that post #20 says would settle it. Nothing in this subcategory is medical advice and several members here are describing experiments on…